Save time and get answers to complex questions with AI chat
Generic brand for latisse?The expiration date of the key patent for guselkumab?Guselkumab brand name?Xiaflex market launch year?Dabrafenib and trametinib price?
Ablysinol has reached Phase 2 clinical development in the U.S., meaning its most advanced U.S. clinical studies are being conducted to evaluate efficacy and safety in patients. [1]
The Phase 2 U.S. development is supported by at least two indication areas: - Cancer - HIV/AIDS [1]
Based on the available development-stage information, the indications explicitly tied to the company’s advanced (Phase 2) U.S. clinical development are cancer and HIV/AIDS. [1] Sources [1] https://www.drugpatentwatch.com/p/ablysinol
Other Questions About Clinical :